 Olfaction Disorders
"Olfaction Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.
| Descriptor ID |
D000857
|
| MeSH Number(s) |
C10.597.751.600 C23.888.592.763.550
|
| Concept/Terms |
Cacosmia- Cacosmia
- Cacosmias
- Dysosmia
- Dysosmias
|
Below are MeSH descriptors whose meaning is more general than "Olfaction Disorders".
Below are MeSH descriptors whose meaning is more specific than "Olfaction Disorders".
This graph shows the total number of publications written about "Olfaction Disorders" by people in this website by year, and whether "Olfaction Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2016 | 2 | 0 | 2 | | 2017 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 2 | 1 | 3 | | 2021 | 4 | 0 | 4 | | 2022 | 4 | 0 | 4 | | 2023 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Olfaction Disorders" by people in Profiles.
-
Miller JE, Taylor-Cousar JL, Humphries SM, Khatiwada A, Chen H, Wilson A, Vladar EK, Lynch DA, Li DA, Beswick DM. Chronic rhinosinusitis and olfaction after highly effective modulator therapy: The role of individual sinus inflammation. Int Forum Allergy Rhinol. 2024 May; 14(5):986-989.
-
Miller JE, Taylor-Cousar JL, Overdevest JB, Khatiwada A, Mace JC, Alt JA, Bodner TE, Chowdhury NI, DiMango EA, Eshaghian PH, Getz AE, Gudis DA, Han EJ, Hwang PH, Keating CL, Khanwalkar A, Kimple AJ, Lee JT, Li D, Markarian K, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Tervo JP, Turner GA, Wang MB, Saavedra MT, Beswick DM. Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy. Int Forum Allergy Rhinol. 2024 Jun; 14(6):1079-1087.
-
Chan KH, Thomas BJ, Gilbert DD, Tong S, Teynor NJ, Friedman NR, Herrmann BW, Gitomer SA. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training. Int J Pediatr Otorhinolaryngol. 2024 Jan; 176:111799.
-
Miller JE, Liu CM, Zemanick ET, Woods JC, Goss CH, Taylor-Cousar JL, Beswick DM. Olfactory loss in people with cystic fibrosis: Community perceptions and impact. J Cyst Fibros. 2024 Nov; 23(6):1195-1198.
-
Biswas K, Ramakrishnan VR, Hollemann E, Lorenz K, Wagner Mackenzie B, Frank DN, Douglas RG, Hummel T. Bacterial communities in the nasal passage of postviral olfactory dysfunction patients. Int Forum Allergy Rhinol. 2023 10; 13(10):1962-1965.
-
Yan CH, Jang SS, Lin HC, Ma Y, Khanwalkar AR, Thai A, Patel ZM. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial. Int Forum Allergy Rhinol. 2023 06; 13(6):989-997.
-
Gitomer SA, Tholen K, Pickett K, Mistry RD, Beswick DM, Kaar JL, Herrmann BW. Olfactory testing as COVID-19 screening in school children; A prospective cross-sectional study. PLoS One. 2022; 17(11):e0277882.
-
Kinnamon SC. Inflammatory-mediated taste dysfunction - Is NO the key? Brain Behav Immun. 2022 10; 105:190-191.
-
Beswick DM, Humphries SM, Balkissoon CD, Strand M, E Miller J, Khatiwada A, Vladar EK, Lynch DA, Taylor-Cousar JL. Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del. Int Forum Allergy Rhinol. 2022 07; 12(7):963-966.
-
Beswick DM, Humphries SM, Balkissoon CD, Strand M, Vladar EK, Ramakrishnan VR, Taylor-Cousar JL. Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy. J Cyst Fibros. 2022 03; 21(2):e141-e147.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|